Member Exclusive News

The week in industry: FDA approves opioid alternative - DSUVIA

This week: US filling for biosimilar of rituximab terminated and BIA granted permission to intervene in Supreme Court case.

Go to the profile of RxNet
Nov 08, 2018
0
0

Please sign in or register for FREE

No comments yet.